Search

Katherine A. Will

Examiner (ID: 13366, Phone: (571)270-0516 , Office: P/1747 )

Most Active Art Unit
1747
Art Unit(s)
1747, 1779
Total Applications
491
Issued Applications
285
Pending Applications
79
Abandoned Applications
153

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6390496 [patent_doc_number] => 20100317917 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-16 [patent_title] => 'FERTILITY ENHANCEMENT USING LIPID CARRIERS AND BIOACTIVE MOLECULES' [patent_app_type] => utility [patent_app_number] => 12/825853 [patent_app_country] => US [patent_app_date] => 2010-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 10460 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20100317917.pdf [firstpage_image] =>[orig_patent_app_number] => 12825853 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/825853
FERTILITY ENHANCEMENT USING LIPID CARRIERS AND BIOACTIVE MOLECULES Jun 28, 2010 Abandoned
Array ( [id] => 8300919 [patent_doc_number] => 20120183477 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-19 [patent_title] => 'Therapeutic Antibody Target Validation and Screening In Vivo' [patent_app_type] => utility [patent_app_number] => 13/378318 [patent_app_country] => US [patent_app_date] => 2010-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 20358 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13378318 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/378318
Therapeutic Antibody Target Validation and Screening In Vivo Jun 24, 2010 Abandoned
Array ( [id] => 6292792 [patent_doc_number] => 20100239615 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-23 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF LUNG CANCER' [patent_app_type] => utility [patent_app_number] => 12/795460 [patent_app_country] => US [patent_app_date] => 2010-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 77110 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20100239615.pdf [firstpage_image] =>[orig_patent_app_number] => 12795460 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/795460
COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF LUNG CANCER Jun 6, 2010 Abandoned
Array ( [id] => 9311828 [patent_doc_number] => 08653046 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-02-18 [patent_title] => 'Controlling transgene expression across the skin' [patent_app_type] => utility [patent_app_number] => 13/263149 [patent_app_country] => US [patent_app_date] => 2010-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 10 [patent_no_of_words] => 8724 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 331 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13263149 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/263149
Controlling transgene expression across the skin Mar 31, 2010 Issued
Array ( [id] => 8227234 [patent_doc_number] => 20120141440 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-07 [patent_title] => 'FOAMYVIRUS VECTORS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 13/259190 [patent_app_country] => US [patent_app_date] => 2010-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 9706 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13259190 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/259190
FOAMYVIRUS VECTORS AND METHODS OF USE Mar 25, 2010 Abandoned
Array ( [id] => 8138443 [patent_doc_number] => 20120093775 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-19 [patent_title] => 'METHODS AND COMPOSITIONS FOR THE TREATMENT OF CIRRHOSIS AND LIVER FIBROSIS' [patent_app_type] => utility [patent_app_number] => 13/260654 [patent_app_country] => US [patent_app_date] => 2010-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 67 [patent_figures_cnt] => 67 [patent_no_of_words] => 31205 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20120093775.pdf [firstpage_image] =>[orig_patent_app_number] => 13260654 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/260654
METHODS AND COMPOSITIONS FOR THE TREATMENT OF CIRRHOSIS AND LIVER FIBROSIS Mar 25, 2010 Abandoned
Array ( [id] => 8336279 [patent_doc_number] => 20120202985 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-09 [patent_title] => 'Hyper IgE Animal Model with Enhanced Immunoglobulin Heavy Chain Class Switching to C-epsilon' [patent_app_type] => utility [patent_app_number] => 13/255226 [patent_app_country] => US [patent_app_date] => 2010-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 18647 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13255226 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/255226
Hyper IgE Animal Model with Enhanced Immunoglobulin Heavy Chain Class Switching to C-epsilon Feb 25, 2010 Abandoned
Array ( [id] => 7657290 [patent_doc_number] => 20110306559 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-15 [patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING NEUROPATHIC PAIN' [patent_app_type] => utility [patent_app_number] => 12/646725 [patent_app_country] => US [patent_app_date] => 2009-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 25260 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20110306559.pdf [firstpage_image] =>[orig_patent_app_number] => 12646725 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/646725
METHODS AND COMPOSITIONS FOR TREATING NEUROPATHIC PAIN Dec 22, 2009 Abandoned
Array ( [id] => 7513003 [patent_doc_number] => 20110258713 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => 'COMPOSITIONS AND METHODS FOR RE-PROGRAMMING CELLS WITHOUT GENETIC MODIFICATION' [patent_app_type] => utility [patent_app_number] => 13/141326 [patent_app_country] => US [patent_app_date] => 2009-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 9452 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20110258713.pdf [firstpage_image] =>[orig_patent_app_number] => 13141326 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/141326
COMPOSITIONS AND METHODS FOR RE-PROGRAMMING CELLS WITHOUT GENETIC MODIFICATION Dec 22, 2009 Abandoned
Array ( [id] => 7491169 [patent_doc_number] => 20110252486 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-13 [patent_title] => 'CHONDROCYTE-LIKE CELL, AND METHOD FOR PRODUCING SAME' [patent_app_type] => utility [patent_app_number] => 13/140164 [patent_app_country] => US [patent_app_date] => 2009-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 14349 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0252/20110252486.pdf [firstpage_image] =>[orig_patent_app_number] => 13140164 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/140164
CHONDROCYTE-LIKE CELL, AND METHOD FOR PRODUCING SAME Dec 17, 2009 Abandoned
Array ( [id] => 7504204 [patent_doc_number] => 20110265194 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'THEM5-MODIFIED MODELS OF NON-ALCOHOLIC FATTY LIVER DISEASE' [patent_app_type] => utility [patent_app_number] => 13/126344 [patent_app_country] => US [patent_app_date] => 2009-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9716 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0265/20110265194.pdf [firstpage_image] =>[orig_patent_app_number] => 13126344 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/126344
THEM5-MODIFIED MODELS OF NON-ALCOHOLIC FATTY LIVER DISEASE Oct 28, 2009 Abandoned
Array ( [id] => 6182734 [patent_doc_number] => 20110179505 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-21 [patent_title] => 'RODENT CANCER MODEL FOR HUMAN FGFR4 ARG388 POLYMORPHISM' [patent_app_type] => utility [patent_app_number] => 13/121202 [patent_app_country] => US [patent_app_date] => 2009-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 65 [patent_figures_cnt] => 65 [patent_no_of_words] => 27685 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0179/20110179505.pdf [firstpage_image] =>[orig_patent_app_number] => 13121202 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/121202
RODENT CANCER MODEL FOR HUMAN FGFR4 ARG388 POLYMORPHISM Sep 28, 2009 Abandoned
Array ( [id] => 7500557 [patent_doc_number] => 20110263015 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'COMPOSITIONS AND METHODS FOR GENERATION OF PLURIPOTENT STEM CELLS' [patent_app_type] => utility [patent_app_number] => 13/059951 [patent_app_country] => US [patent_app_date] => 2009-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 15816 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20110263015.pdf [firstpage_image] =>[orig_patent_app_number] => 13059951 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/059951
COMPOSITIONS AND METHODS FOR GENERATION OF PLURIPOTENT STEM CELLS Aug 19, 2009 Abandoned
Array ( [id] => 8064929 [patent_doc_number] => 20110244575 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'METHODS, SYSTEMS AND COMPOSITIONS FOR INCREASED MICROORGANISM TOLERANCE TO AND PRODUCTION OF 3-HYDROXYPROPIONIC ACID (3-HP)' [patent_app_type] => utility [patent_app_number] => 13/055138 [patent_app_country] => US [patent_app_date] => 2009-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 48 [patent_no_of_words] => 51014 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20110244575.pdf [firstpage_image] =>[orig_patent_app_number] => 13055138 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/055138
METHODS, SYSTEMS AND COMPOSITIONS FOR INCREASED MICROORGANISM TOLERANCE TO AND PRODUCTION OF 3-HYDROXYPROPIONIC ACID (3-HP) Jul 22, 2009 Abandoned
Array ( [id] => 8504909 [patent_doc_number] => 20120304317 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-29 [patent_title] => 'TRANSGENIC RODENT EXPRESSING TRUNCATED DISC1' [patent_app_type] => utility [patent_app_number] => 13/054444 [patent_app_country] => US [patent_app_date] => 2009-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 61 [patent_figures_cnt] => 61 [patent_no_of_words] => 16624 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13054444 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/054444
TRANSGENIC RODENT EXPRESSING TRUNCATED DISC1 Jul 15, 2009 Abandoned
Array ( [id] => 9503296 [patent_doc_number] => 08741607 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-03 [patent_title] => 'HCV/GBV-B chimeric virus' [patent_app_type] => utility [patent_app_number] => 13/054356 [patent_app_country] => US [patent_app_date] => 2009-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14511 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13054356 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/054356
HCV/GBV-B chimeric virus Jul 14, 2009 Issued
Array ( [id] => 7653396 [patent_doc_number] => 20110302665 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-08 [patent_title] => 'NON-HUMAN MAMMALS WITH T OR B CELLS HAVING PREDEFINED SPECIFICITY' [patent_app_type] => utility [patent_app_number] => 13/002334 [patent_app_country] => US [patent_app_date] => 2009-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 27053 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0302/20110302665.pdf [firstpage_image] =>[orig_patent_app_number] => 13002334 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/002334
NON-HUMAN MAMMALS WITH T OR B CELLS HAVING PREDEFINED SPECIFICITY Jul 1, 2009 Abandoned
Array ( [id] => 8138437 [patent_doc_number] => 20120093772 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-19 [patent_title] => 'VECTORS FOR DELIVERY OF LIGHT SENSITIVE PROTEINS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 12/993092 [patent_app_country] => US [patent_app_date] => 2009-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 17950 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20120093772.pdf [firstpage_image] =>[orig_patent_app_number] => 12993092 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/993092
VECTORS FOR DELIVERY OF LIGHT SENSITIVE PROTEINS AND METHODS OF USE May 19, 2009 Abandoned
Array ( [id] => 5495334 [patent_doc_number] => 20090263362 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-22 [patent_title] => 'FERTILITY ENHANCEMENT USING LIPID CARRIERS AND BIOACTIVE MOLECULES' [patent_app_type] => utility [patent_app_number] => 12/412810 [patent_app_country] => US [patent_app_date] => 2009-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 18341 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20090263362.pdf [firstpage_image] =>[orig_patent_app_number] => 12412810 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/412810
FERTILITY ENHANCEMENT USING LIPID CARRIERS AND BIOACTIVE MOLECULES Mar 26, 2009 Abandoned
Array ( [id] => 6134393 [patent_doc_number] => 20110008295 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'SIMIAN ADENOVIRUSES SADV-36, -42.1, -42.2, AND -44 AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/920648 [patent_app_country] => US [patent_app_date] => 2009-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 21057 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20110008295.pdf [firstpage_image] =>[orig_patent_app_number] => 12920648 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/920648
Simian adenoviruses SAdV-36, -42.1, -42.2, and -44 and uses thereof Mar 2, 2009 Issued
Menu